Copyright Reports & Markets. All rights reserved.

Global Artificial Blood Cells Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Artificial Blood Cells Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Animal Hemoglobin
    • 1.3.3 Human Hemoglobin
    • 1.3.4 Stem Cell
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Artificial Blood Cells Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Cardiovascular Diseases
    • 1.4.3 Anemia
    • 1.4.4 Organ Transplant
    • 1.4.5 Others
  • 1.5 Global Artificial Blood Cells Market Size & Forecast
    • 1.5.1 Global Artificial Blood Cells Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Artificial Blood Cells Sales Quantity (2020-2031)
    • 1.5.3 Global Artificial Blood Cells Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Dextro-Sang Corporation
    • 2.1.1 Dextro-Sang Corporation Details
    • 2.1.2 Dextro-Sang Corporation Major Business
    • 2.1.3 Dextro-Sang Corporation Artificial Blood Cells Product and Services
    • 2.1.4 Dextro-Sang Corporation Artificial Blood Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Dextro-Sang Corporation Recent Developments/Updates
  • 2.2 BioPure Corporation
    • 2.2.1 BioPure Corporation Details
    • 2.2.2 BioPure Corporation Major Business
    • 2.2.3 BioPure Corporation Artificial Blood Cells Product and Services
    • 2.2.4 BioPure Corporation Artificial Blood Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 BioPure Corporation Recent Developments/Updates
  • 2.3 Sangart
    • 2.3.1 Sangart Details
    • 2.3.2 Sangart Major Business
    • 2.3.3 Sangart Artificial Blood Cells Product and Services
    • 2.3.4 Sangart Artificial Blood Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Sangart Recent Developments/Updates
  • 2.4 Northfield Laboratories
    • 2.4.1 Northfield Laboratories Details
    • 2.4.2 Northfield Laboratories Major Business
    • 2.4.3 Northfield Laboratories Artificial Blood Cells Product and Services
    • 2.4.4 Northfield Laboratories Artificial Blood Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Northfield Laboratories Recent Developments/Updates
  • 2.5 Baxter International
    • 2.5.1 Baxter International Details
    • 2.5.2 Baxter International Major Business
    • 2.5.3 Baxter International Artificial Blood Cells Product and Services
    • 2.5.4 Baxter International Artificial Blood Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Baxter International Recent Developments/Updates
  • 2.6 Dentritech
    • 2.6.1 Dentritech Details
    • 2.6.2 Dentritech Major Business
    • 2.6.3 Dentritech Artificial Blood Cells Product and Services
    • 2.6.4 Dentritech Artificial Blood Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Dentritech Recent Developments/Updates
  • 2.7 FluorO2 Therapeutics
    • 2.7.1 FluorO2 Therapeutics Details
    • 2.7.2 FluorO2 Therapeutics Major Business
    • 2.7.3 FluorO2 Therapeutics Artificial Blood Cells Product and Services
    • 2.7.4 FluorO2 Therapeutics Artificial Blood Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 FluorO2 Therapeutics Recent Developments/Updates
  • 2.8 Nuvox Pharma
    • 2.8.1 Nuvox Pharma Details
    • 2.8.2 Nuvox Pharma Major Business
    • 2.8.3 Nuvox Pharma Artificial Blood Cells Product and Services
    • 2.8.4 Nuvox Pharma Artificial Blood Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Nuvox Pharma Recent Developments/Updates
  • 2.9 Alpha Therapeutic Corporation
    • 2.9.1 Alpha Therapeutic Corporation Details
    • 2.9.2 Alpha Therapeutic Corporation Major Business
    • 2.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Product and Services
    • 2.9.4 Alpha Therapeutic Corporation Artificial Blood Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Alpha Therapeutic Corporation Recent Developments/Updates
  • 2.10 HemoBioTech
    • 2.10.1 HemoBioTech Details
    • 2.10.2 HemoBioTech Major Business
    • 2.10.3 HemoBioTech Artificial Blood Cells Product and Services
    • 2.10.4 HemoBioTech Artificial Blood Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 HemoBioTech Recent Developments/Updates

3 Competitive Environment: Artificial Blood Cells by Manufacturer

  • 3.1 Global Artificial Blood Cells Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Artificial Blood Cells Revenue by Manufacturer (2020-2025)
  • 3.3 Global Artificial Blood Cells Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Artificial Blood Cells by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Artificial Blood Cells Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Artificial Blood Cells Manufacturer Market Share in 2024
  • 3.5 Artificial Blood Cells Market: Overall Company Footprint Analysis
    • 3.5.1 Artificial Blood Cells Market: Region Footprint
    • 3.5.2 Artificial Blood Cells Market: Company Product Type Footprint
    • 3.5.3 Artificial Blood Cells Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Artificial Blood Cells Market Size by Region
    • 4.1.1 Global Artificial Blood Cells Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Artificial Blood Cells Consumption Value by Region (2020-2031)
    • 4.1.3 Global Artificial Blood Cells Average Price by Region (2020-2031)
  • 4.2 North America Artificial Blood Cells Consumption Value (2020-2031)
  • 4.3 Europe Artificial Blood Cells Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Artificial Blood Cells Consumption Value (2020-2031)
  • 4.5 South America Artificial Blood Cells Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Artificial Blood Cells Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Artificial Blood Cells Sales Quantity by Type (2020-2031)
  • 5.2 Global Artificial Blood Cells Consumption Value by Type (2020-2031)
  • 5.3 Global Artificial Blood Cells Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Artificial Blood Cells Sales Quantity by Application (2020-2031)
  • 6.2 Global Artificial Blood Cells Consumption Value by Application (2020-2031)
  • 6.3 Global Artificial Blood Cells Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Artificial Blood Cells Sales Quantity by Type (2020-2031)
  • 7.2 North America Artificial Blood Cells Sales Quantity by Application (2020-2031)
  • 7.3 North America Artificial Blood Cells Market Size by Country
    • 7.3.1 North America Artificial Blood Cells Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Artificial Blood Cells Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Artificial Blood Cells Sales Quantity by Type (2020-2031)
  • 8.2 Europe Artificial Blood Cells Sales Quantity by Application (2020-2031)
  • 8.3 Europe Artificial Blood Cells Market Size by Country
    • 8.3.1 Europe Artificial Blood Cells Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Artificial Blood Cells Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Artificial Blood Cells Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Artificial Blood Cells Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Artificial Blood Cells Market Size by Region
    • 9.3.1 Asia-Pacific Artificial Blood Cells Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Artificial Blood Cells Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Artificial Blood Cells Sales Quantity by Type (2020-2031)
  • 10.2 South America Artificial Blood Cells Sales Quantity by Application (2020-2031)
  • 10.3 South America Artificial Blood Cells Market Size by Country
    • 10.3.1 South America Artificial Blood Cells Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Artificial Blood Cells Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Artificial Blood Cells Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Artificial Blood Cells Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Artificial Blood Cells Market Size by Country
    • 11.3.1 Middle East & Africa Artificial Blood Cells Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Artificial Blood Cells Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Artificial Blood Cells Market Drivers
  • 12.2 Artificial Blood Cells Market Restraints
  • 12.3 Artificial Blood Cells Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Artificial Blood Cells and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Artificial Blood Cells
  • 13.3 Artificial Blood Cells Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Artificial Blood Cells Typical Distributors
  • 14.3 Artificial Blood Cells Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Artificial Blood Cells market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
    According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
    Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
    This report is a detailed and comprehensive analysis for global Artificial Blood Cells market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Artificial Blood Cells market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Artificial Blood Cells market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Artificial Blood Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Artificial Blood Cells market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Artificial Blood Cells
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Artificial Blood Cells market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Artificial Blood Cells market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Animal Hemoglobin
    Human Hemoglobin
    Stem Cell
    Others
    Market segment by Application
    Cardiovascular Diseases
    Anemia
    Organ Transplant
    Others
    Major players covered
    Dextro-Sang Corporation
    BioPure Corporation
    Sangart
    Northfield Laboratories
    Baxter International
    Dentritech
    FluorO2 Therapeutics
    Nuvox Pharma
    Alpha Therapeutic Corporation
    HemoBioTech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Artificial Blood Cells product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Artificial Blood Cells, with price, sales quantity, revenue, and global market share of Artificial Blood Cells from 2020 to 2025.
    Chapter 3, the Artificial Blood Cells competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Artificial Blood Cells breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Artificial Blood Cells market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Artificial Blood Cells.
    Chapter 14 and 15, to describe Artificial Blood Cells sales channel, distributors, customers, research findings and conclusion.

    Buy now